| Filed On | Filing |
|---|---|
| 05 Nov 2026 |
8-K: Results of Operations and Financial Condition
Charlotte, N.C., November 5, 2026 - DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2026. |
| 09 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
Execution Version US-DOCS\175389575.2 THIRD AMENDMENT TO CREDIT AGREEMENT This THIRD AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of September 30, 2026, among DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”), th... |
| 06 Aug 2026 |
8-K: Financial Statements and Exhibits
Charlotte, N.C., August 6, 2026 - DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2026. |
| 11 Jun 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
P a g e 1 | 4 May 29, 2026 John Fortson [email protected] Dear John, On behalf of Dentsply Sirona, I am pleased to offer you the role of Executive Vice President & Chief Financial Officer. In this role, you will report to Dan Sc... |
| 04 Jun 2026 |
8-K: Submission of Matters to a Vote of Security Holders
The annual meeting of stockholders (the “Annual Meeting”) of DENTSPLY SIRONA Inc. (the “Company”) was held on June 2, 2026. The following matters were voted upon at the Annual Meeting, with the results indicated: |
| 05 May 2026 |
8-K: Results of Operations and Financial Condition
Charlotte, N.C., May 5, 2026 - DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2026. |
| 26 Feb 2026 |
8-K: Results of Operations and Financial Condition
Charlotte, N.C., February 26, 2026 – DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced its financial results for the fourth quarter and full year of 2025. |
| 24 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors - New directors bring decades of financial leadership and board experience to enhance strategic oversight of Return-to-Growth action plan and long-term value cr... |
| 14 Jan 2026 |
8-K: Regulation FD Disclosure
Registered brands, trade names and logos are used. Even in particular cases, when they appear without a TM or ®, all corresponding legal rules and provisions apply. All rights are retained by Dentsply Sirona. Clinicians may have been com... |
| 13 Jan 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
Dentsply Sirona Appoints Donald Zurbay to Board of Directors - Company’s Board of Directors forms Growth and Value Creation Committee to guide the Company’s Return-to-Growth Action Plan Charlotte, N.C., January 13, 2026 – DENTSPLY SIRONA... |
| 31 Dec 2025 |
8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
Execution Version US-DOCS\166070569.6 SECOND AMENDMENT TO CREDIT AGREEMENT This SECOND AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of December 24, 2025, among DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”), t... |
| 25 Nov 2025 |
8-K: Other Events
On November 25, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced the appointment of Michael Pomeroy as the Company’s interim Chief Financial Officer, who will serve in this temporary capacity until the Company identifies and appoints... |
| 06 Nov 2025 |
8-K: Results of Operations and Financial Condition
Charlotte, N.C., November 6, 2025 - DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the third quarter of 2025 and introduced its Return-to-Growth action plan, a comprehen... |
| 06 Nov 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On October 31, 2025, DENTSPLY SIRONA Inc. (the “Company”) determined that Matthew E. Garth will no longer serve as the Executive Vice President and Chief Financial Officer of the Company effective November 5, 2025. The Company has initia... |
| 14 Oct 2025 |
8-K: Other Events
On October 14, 2025, DENTSPLY SIRONA Inc. (the “Company”) announced that the Division of Enforcement of the Securities and Exchange Commission (the “SEC”) has concluded its investigation of the Company commenced in May 2022 (the “SEC Inv... |
| 03 Oct 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
EXECUTION VERSION 1 Transition, Separation and Release of Claims Agreement This Transition, Separation and Release of Claims Agreement (this “Agreement”) is entered into by and between DENTSPLY SIRONA Inc., a Delaware corporation (the “E... |
| 19 Sep 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 19, 2025, the Compensation & Human Capital Committee (the “Committee”) of the Board of Directors (the “Board”) of DENTSPLY SIRONA Inc. (the “Company”) approved a one-time retention equity incentive award under the DENTSPLY S... |
| 08 Sep 2025 |
8-K: Regulation FD Disclosure
Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the ... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition
Charlotte, N.C., August 7, 2025 - DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (Nasdaq: XRAY) today announced its financial results for the second quarter of 2025. |
| 21 Jul 2025 |
8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more
Employment Agreement This Employment Agreement (this “Agreement”), is entered into as of July 18, 2025 (the “Effective Date”) by and between DENTSPLY SIRONA Inc., a Delaware corporation (the “Company”) and Daniel Scavilla (“Executive”) (... |
Loading...